KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $428,279 | -10.1% | 1,975 | -18.5% | 0.16% | -25.8% |
Q4 2022 | $476,316 | +29.8% | 2,424 | -19.2% | 0.22% | +952.4% |
Q3 2021 | $367,000 | -3.7% | 3,000 | -10.2% | 0.02% | 0.0% |
Q2 2021 | $381,000 | -9.5% | 3,339 | -19.5% | 0.02% | -58.0% |
Q4 2020 | $421,000 | – | 4,148 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |